Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Testolactone | |
| Synonyms |
|
|
| Definitions |
A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C2301 |
|
| CAS_Registry |
968-93-4
|
|
| CHEBI_ID |
CHEBI:9460
|
|
| Chemical_Formula |
C19H24O3
|
|
| code |
C2301
|
|
| Contributing_Source |
FDA
|
|
| definition |
A progesterone derivative with antineoplastic activity. Testolactone inhibits steroid aromatase, thereby preventing the formation of estrogen from adrenal androstenedione and reducing endogenous estrogen levels. (NCI04)
|
|
| FDA_UNII_Code |
6J9BLA949Q
|
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
| Is_Value_For_GDC_Property | ||
| label |
Testolactone
|
|
| Legacy Concept Name |
Testolactone
|
|
| Maps_To |
Testolactone
|
|
| NCI_Drug_Dictionary_ID |
42916
|
|
| NSC Number |
23759
|
|
| PDQ_Closed_Trial_Search_ID |
42916
|
|
| PDQ_Open_Trial_Search_ID |
42916
|
|
| Preferred_Name |
Testolactone
|
|
| prefixIRI |
NCIT:C2301
|
|
| prefLabel |
Testolactone
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance Hormone
|
|
| UMLS_CUI |
C0039600
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping